Lung Cancer Clinical Trials

Showing 2361-2380 of 4,288 trials

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)

NCT04721444

Distinguishing changes on patients that have received thoracic radiotherapy and patients that are currently receiving or have recently received IO and presenting lung changes which will be identified using AI.

Lung CancerCovid19Pneumonitis

Royal Marsden NHS Foundation Trust1,211 participantsStarted Jan 2021

London, United Kingdom • London, United Kingdom • London, United Kingdom

COMPLETEDNA

Application of Ultrasound-Guided Thoracic Paravertebral Block in Pulmonary Ablation Surgery

NCT05437718

Local thermal ablation therapy of tumor is a rapidly developing minimally invasive therapy for lung tumors in recent years. This study evaluated the efficacy of thoracic paravertebral block (TPVB) for anaesthesia during ablation surgery of lung tumor.

Lung Cancer

Affiliated Hospital of Nantong University30 participantsStarted Dec 2021

Nantong, Jiangsu, China

COMPLETEDPhase 2

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

NCT01721759

The purpose of the study is to assess the objective response rate (change in tumor size from baseline) in patients with advanced or metastatic squamous cell nonsmall-cell lung cancer treated with Nivolumab (BMS-936558) after failure of 2 prior systemic regimens

Squamous Cell Non-small Cell Lung Cancer

Bristol-Myers Squibb117 participantsStarted Nov 2012

Sacramento, California, United States • San Diego, California, United States • Tampa, Florida, United States +30 more locations

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)

Application of Ultrasound-Guided Thoracic Paravertebral Block in Pulmonary Ablation Surgery

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Related Searches

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle

Intraoperative Imaging of Pulmonary Nodules by SGM-101

A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma

A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study

Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine Adequacy

Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer

Immune Boost In Non-Small Cell Lung Cancer

Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT)

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive